Compound Detail
CHEMBL2137199
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
OC(c1ccc(-c2ccc(CN3CCN(Cc4ccncc4)CC3)cc2)c(F)c1)(C(F)(F)F)C(F)(F)F
Basic Information
| ChEMBL ID | CHEMBL2137199 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | KVHKWAZUPPBMLL-UHFFFAOYSA-N |
6
Targets
20
Activities
3
Assay Types
3
PK Parameters
20
Publications
0
Known Names
Molecular Properties
527.5
MW (Da)
5.52
ALogP
4
HBA
1
HBD
39.6
PSA (Ų)
0.43
QED
2
Ro5 Violations
6
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 17 meas. best 6.96
Ki 2 meas. best 6.98
EC50 1 meas. best 6.5
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Nuclear receptor ROR-gamma CHEMBL1741186 | Ki | 6.98 | 6.98 | 105.0 | 2 |
| Nuclear receptor ROR-gamma CHEMBL1741186 | IC50 | 6.96 | 6.3911 | 110.0 | 9 |
| Nuclear receptor ROR-gamma CHEMBL1741186 | EC50 | 6.5 | 6.5 | 320.0 | 1 |
| LNCaP C4-2B CHEMBL4296461 | IC50 | 5.27 | 5.135 | 5380.0 | 2 |
| LNCaP CHEMBL612518 | IC50 | 5.27 | 5.22 | 5380.0 | 2 |
| CWR22R CHEMBL612657 | IC50 | 5.19 | 5.09 | 6420.0 | 2 |
| PC-3 CHEMBL390 | IC50 | 4.61 | 4.61 | 24820.0 | 1 |
| DU-145 CHEMBL613508 | IC50 | 4.34 | 4.34 | 45690.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 8.71 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 12.3 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 48.98 | mL.min-1.g-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL5303300 | HEK-293T | 304 |
| - | 10.6019/CHEMBL5303300 | Fibroblast | 304 |
| - | 10.6019/CHEMBL5303300 | U2OS | 304 |
| - | 10.6019/CHEMBL5303304 | HEK-293T | 9 |
| - | 10.6019/CHEMBL5303304 | Fibroblast | 9 |
| - | 10.6019/CHEMBL5303304 | U2OS | 8 |
| 27043267 | 10.1016/j.ejmech.2016.03.052 | Nuclear receptor ROR-gamma | 5 |
| 24704616 | 10.1016/j.ejmech.2014.03.065 | Nuclear receptor ROR-gamma | 5 |
| - | 10.6019/CHEMBL3301361 | ADMET | 4 |
| - | 10.6019/CHEMBL5724696 | TERT-RPE1 | 4 |
| - | 10.1039/C3MD00005B | Nuclear receptor ROR-gamma | 4 |
| 24502334 | 10.1021/jm401901d | Nuclear receptor ROR-gamma | 3 |
| - | 10.6019/CHEMBL3301361 | No relevant target | 3 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| 30964293 | 10.1021/acs.jmedchem.9b00327 | LNCaP | 1 |
| 30964293 | 10.1021/acs.jmedchem.9b00327 | LNCaP C4-2B | 1 |
| 30964293 | 10.1021/acs.jmedchem.9b00327 | DU-145 | 1 |
| 30964293 | 10.1021/acs.jmedchem.9b00327 | PC-3 | 1 |
Data from ChEMBL 36 via Core Engine